Skip to content

Clinical trials

Phase 3 Lupus Erythematosus, Systemic trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 3 Country / region: Bulgaria Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20112
20181
20201
20213
20224
20234
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting8
Completed5
Recruiting4
Enrolling by invitation3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Biogen2
Bristol-Myers Squibb2
EMD Serono Research & Development Institute, Inc.2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
UCB Biopharma SRL2
UCB Pharma2
Viatris Innovation GmbH2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic23
Autoimmune Diseases6
Connective Tissue Diseases6
Immune System Diseases6
Lupus Erythematosus, Cutaneous2
Lupus Erythematosus, Discoid2
Lupus Nephritis2
Nephritis1
Skin and Connective Tissue Diseases1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.